← Open Payments lookup

BEVERLY DRISKILL: Open Payments

NPI 1689762122 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$655 in 29 payments from 10 companies in 2025. Trend: 2023 $849 · 2024 $80 · 2025 $655

Food & beverage: $655
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.8$211
Neurocrine BioSciences, Inc.4$109
Otsuka America Pharmaceutical, Inc.4$75
Alkermes, Inc.2$61
Teva Pharmaceuticals USA, Inc.3$53
Supernus Pharmaceuticals, Inc.3$43
ABBVIE INC.2$38
Axsome Therapeutics, Inc.1$28
Janssen Pharmaceuticals, Inc1$24
Lundbeck LLC1$14

Products named: COBENFY, INGREZZA, ARISTADA, Qelbree, ABILIFY ASIMTUFII, VRAYLAR, UZEDY, REXULTI.

Industry payments across NV — which companies pay providers there.